Bags of shredded docs: Indian drugmaker Lupin handed a Form 483 by FDA inspectors
The generics manufacturer Lupin has been given another Form 483 from the FDA this year.
US regulators inspected Lupin’s pharmaceutical manufacturing site in the town …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.